Tuesday Mar 9 | PR-inside.com
'Taiwan Pharmaceuticals & Healthcare Report Q2 2010' Published
Combined sales of prescription products and over-the-counter medicines reached US$3.58bn in 2008 - a 3.8% increase compared to the previous year.
University of Chicago Antihypertensive Combo May Save Kidney Function
Patients with chronic kidney disease treated with benazepril plus amlodipine were less likely to experience worsening renal function than those treated with benazepril plus hydrochlorothiazide, analysis of data from a randomized trial found.
Pfizer posts big jump in 4Q sales, profit
Drugmaker Pfizer Inc., well into integrating its new Wyeth unit, posted a 34 percent jump in revenue Wednesday, but $3.2 billion in acquisition and restructuring charges and higher costs across the board weighed down profit.
'Sex Headaches,' High Blood Pressure
Q: I started suffering from horrible headaches at climax about seven or eight years ago.
More study needed on nasal capsaicin
Q: Can you comment on the efficacy and safety of nasal capsaicin for rhinitis, sinusitis or sinus headache? A: Capsaicin is the hot substance that gives chiles their kick.
I'm taking Norvasc, Atenolol and a statin cholesterol drug, Crestor. The side effects are intolerable.
There are many disorders of the human body which thankfully are treatable with medications.
New market report: Taiwan Drug spending accounts for 0.94% of GDP
Combined sales of prescription products and over-the-counter medicines reached US$3.58bn in 2008 - a 3.8% increase compared to the previous year.
Part D Negotiation Will Save Medicare And Seniors Billions
Main Category: Medicare / Medicaid / SCHIP Also Included In: Seniors / Aging Article Date: 30 Oct 2009 An analysis by the National Committee to Preserve Social Security and Medicare shows that health care reform proposals, which allow Medicare to negotiate the lowest drug prices for beneficiaries in Part D, would save $24 billion each year.
Pfizer reports 26% profit jump, but lower sales
Pfizer Inc. reported a 26% spike in third-quarter profit early Tuesday, helped by lower expenses and charges taken in the 2008 quarter for litigation.
A Drugmaker That'll Actually Take Off with Health Reform
Founded in Jerusalem in 1901, Teva is the only drugmaker that is a leader in both generics and branded pharmaceuticals.
Also on Topix